Iovance Biotherapeutics, Inc.
IOVA
Revenue
67.46M
▲7.50M▲12.52%
3 Months ChangeAssets
904.95M
▼-2.49M▼-0.2743%
3 Months ChangeLiabilities
202.66M
▼-6.29M▼-3.01%
3 Months ChangeFree Cash Flow
-109.91M
▲16.55M▲13.08%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-09
Form 8-K
ID: 0001104659-24-087876
2024-08-08
Form 10-Q
ID: 0001558370-24-011641
2024-08-08
Form 8-K
ID: 0001104659-24-087259
2024-06-28
Form 8-K
ID: 0001104659-24-075997
2024-06-11
Form 8-K
ID: 0001104659-24-070470
2024-06-03
Form 8-K
ID: 0001104659-24-067485
2024-05-24
Form 8-K
ID: 0001104659-24-064825
2024-05-09
Form 10-Q
ID: 0001558370-24-007646
2024-05-09
Form 8-K
ID: 0001104659-24-059322
2024-04-03
Form 8-K
ID: 0001104659-24-043158